SEC Filings TLDR

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5% ownership stake in Rithm Capital Corp. The filing indicates that BlackRock beneficially owns 26,550,891 shares of Rithm Capital's common stock, with sole voting power over 24,461,001 shares and sole dispositive power over all 26,550,891 shares. The ...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.3% ownership stake in Navitas Semiconductor Corp. The filing indicates that BlackRock beneficially owns 11,335,272 shares of the company's common stock, with sole voting power over 11,038,843 shares and sole dispositive power over all 11,335,272 shar...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Nano Nuclear Energy Inc. As of September 30, 2025, BlackRock beneficially owns 2,226,670 shares of common stock, representing 5.4% of the total outstanding shares. This marks a significant increase from previous holdings, ...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.1% ownership stake in MODIV INDUSTRIAL INC. The filing indicates that BlackRock beneficially owns 521,743 shares of Class C Stock, with sole voting power over 508,330 shares and sole dispositive power over all 521,743 shares. The filing also notes th...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.5% ownership stake in LOANDEPOT INC CLASS A. The filing indicates that BlackRock beneficially owns 6,228,200 shares of the company's common stock. The shares are held in the ordinary course of business and not for the purpose of influencing control o...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.8% ownership in Lifevantage Corp. The filing indicates that BlackRock beneficially owns 732,063 shares of Lifevantage Corp's common stock. The shares are held in the ordinary course of business and not for the purpose of influencing control of the is...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in LENZ THERAPEUTICS, INC. As of the effective date of October 17, 2025, BlackRock, Inc. beneficially owns 1,442,864 shares of common stock, representing 5.1% of the total outstanding shares. This marks a significant increase...

BlackRock, Inc. filed a Schedule 13G with the SEC on October 17, 2025, disclosing a 5.2% ownership stake in LENSAR, Inc. The filing indicates that BlackRock beneficially owns 623,381 shares of LENSAR's common stock, with sole voting power over 616,906 shares and sole dispositive power over all 623,381 shares. The filin...

BlackRock, Inc. has filed a Schedule 13G with the SEC, reporting a 5.1% ownership in Dakota Gold Corp. The filing indicates that BlackRock beneficially owns 5,708,431 shares of common stock, with sole voting power over 5,625,537 shares and sole dispositive power over all 5,708,431 shares. The filing also notes that var...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased stake in iShares MSCI India ETF. As of the snapshot date on October 17, 2025, BlackRock, Inc. beneficially owns 14,867,393 shares, representing 8.5% of the total outstanding common stock. This marks a significant increase from previous holdi...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.7% ownership stake in Guardian Pharmacy Services, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 1,306,624 shares of Class A Stock, with sole voting power over 1,271,373 shares and sole dispositive power over all...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.3% ownership in Gitlab Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 7,797,696 shares of Gitlab's Class A Stock. The shares are held in the ordinary course of business and not for the purpose of influencing cont...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.2% ownership stake in GAIA, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 1,027,164 shares of GAIA's Class A Stock, with sole voting power over 1,001,723 shares and sole dispositive power over all 1,027,164 shar...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.9% ownership in GCI Liberty Inc. as of September 30, 2025. The filing indicates that BlackRock, Inc. beneficially owns 1,447,650 shares of GCI Liberty Inc.'s Series C Common Stock. The shares are held in the ordinary course of business and not for th...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.8% ownership in GCI Liberty Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 210,916 shares of GCI Liberty's Series A Common Stock, with sole voting power over 204,164 shares and sole dispositive power over all 210...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.1% ownership stake in First Watch Restaurant Group, Inc. The filing indicates that BlackRock beneficially owns 3,115,700 shares of common stock, with sole voting power over 3,041,460 shares and sole dispositive power over all 3,115,700 shares. The fi...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership stake in Elanco Animal Health Inc. As of September 30, 2025, BlackRock beneficially owns 44,021,766 shares of Elanco's common stock, representing 8.9% of the total outstanding shares. This marks a significant increase from previous...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5% ownership stake in DraftKings Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 24,834,364 shares of DraftKings' Class A Stock, with sole voting power over 22,941,537 shares and sole dispositive power over all 24,8...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.01% ownership stake in Delcath Systems, Inc. The filing indicates that BlackRock beneficially owns 1,753,024 shares of Delcath's common stock, with sole voting power over 1,719,092 shares and sole dispositive power over all 1,753,024 shares. The fili...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.01% ownership stake in C & F FINANCIAL CORP. The filing indicates that BlackRock beneficially owns 162,441 shares of the company's common stock, with sole voting power over 157,672 shares and sole dispositive power over all 162,441 shares. The filing...

BlackRock, Inc. has filed a Schedule 13G with the SEC, reporting a 5.3% ownership in BrightView Holdings Inc. as of September 30, 2025. The filing indicates that BlackRock, Inc. beneficially owns 5,041,087 shares of BrightView's common stock, with sole voting power over 4,883,631 shares and sole dispositive power over ...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing an increased ownership in BETA BIONICS INC. As of the snapshot date of October 17, 2025, BlackRock, Inc. beneficially owns 2,778,764 shares of BETA BIONICS INC's common stock, representing 6.4% of the total outstanding shares. This marks a significant in...

BlackRock, Inc. has filed a Schedule 13G with the SEC, reporting a 5.4% ownership in BV Financial Inc. as of September 30, 2025. The filing indicates that BlackRock, Inc. beneficially owns 536,009 shares of BV Financial Inc.'s common stock. The shares are held in the ordinary course of business and not for the purpose ...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.4% ownership stake in Aura Biosciences Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 3,336,027 shares of Aura Biosciences' common stock, with sole voting power over 3,274,730 shares and sole dispositive power ov...

BlackRock, Inc. has filed a Schedule 13G with the SEC, disclosing a 5.02% ownership stake in Astera Labs Inc. The filing indicates that BlackRock beneficially owns 8,352,673 shares of Astera Labs' common stock. The shares are held in the ordinary course of business and not for the purpose of influencing control of the ...